0001209191-15-053020.txt : 20150612 0001209191-15-053020.hdr.sgml : 20150612 20150612201500 ACCESSION NUMBER: 0001209191-15-053020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150610 FILED AS OF DATE: 20150612 DATE AS OF CHANGE: 20150612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDENBERG CYNTHIA L CENTRAL INDEX KEY: 0001202016 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 15929832 MAIL ADDRESS: STREET 1: C/O XIMMUNOMEDICS INC STREET 2: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN CYNTHIA L DATE OF NAME CHANGE: 20021029 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-10 0 0000722830 IMMUNOMEDICS INC IMMU 0001202016 GOLDENBERG CYNTHIA L C/O IMMUNOMEDICS, INC. 300 AMERICAN ROAD MORRIS PLAINS NJ 07950 1 1 0 0 President and CEO Common Stock 2015-06-10 4 M 0 15300 2.67 A 524857 D Common Stock 2015-06-10 4 S 0 15300 4.6751 D 509557 D Common Stock 2015-06-10 4 M 0 15120 2.67 A 5296537 I See footnote Common Stock 2015-06-10 4 S 0 15120 4.6745 D 5281417 I See footnote Common Stock 2015-06-11 4 M 0 84700 2.67 A 594257 D Common Stock 2015-06-11 4 S 0 84700 4.3035 D 509557 D Common Stock 2015-06-11 4 M 0 21191 1.75 A 530748 D Common Stock 2015-06-11 4 S 0 21191 4.3035 D 509557 D Common Stock 2015-06-11 4 M 0 93989 2.67 A 5375406 I See footnote Common Stock 2015-06-11 4 S 0 93989 4.3046 D 5281417 I See footnote Common Stock 2015-06-12 4 M 0 58512 1.75 A 568069 D Common Stock 2015-06-12 4 S 0 58512 4.2672 D 509557 D Common Stock 2015-06-12 4 M 0 70841 2.67 A 5352258 I See footnote Common Stock 2015-06-12 4 S 0 70841 4.2668 D 5281417 I See footnote Stock Option (right to buy) 2.67 2015-06-10 4 M 0 15300 0.00 D 2015-07-18 Common Stock, par value $0.01 per share 15300 84700 D Stock Option (right to buy) 2.67 2015-06-10 4 M 0 15120 0.00 D 2015-07-18 Common Stock, par value $0.01 per share 15120 284880 I See footnote Stock Option (right to buy) 2.67 2015-06-11 4 M 0 84700 0.00 D 2015-07-18 Common Stock, par value $0.01 per share 84700 0 D Stock Option (right to buy) 1.75 2015-06-11 4 M 0 21191 0.00 D 2015-06-15 Common Stock, par value $0.01 per share 21191 128809 D Stock Option (right to buy) 2.67 2015-06-11 4 M 0 93989 0.00 D 2015-07-18 Common Stock, par value $0.01 per share 93989 190891 I See footnote Stock Option (right to buy) 1.75 2015-06-12 4 M 0 58512 0.00 D 2015-06-15 Common Stock, par value $0.01 per share 58512 70297 D Stock Option (right to buy) 2.67 2015-06-12 4 M 0 70841 0.00 D 2015-07-18 Common Stock, par value $0.01 per share 70841 120050 I See footnote Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Medical Officer and Chairman of the Board of Directors. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.65 to $4.71. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein. The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.21 to 4.61. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.21 to 4.34. These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter. The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan. These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested immediately. /s/ Cynthia L. Goldenberg 2015-06-12